Analysis of risk factors of severe retinopathy of prematurity

( views:, downloads: )
SHAN Hai-dong()
ZHAO Pei-quan()
JIANG Ding-feng()
Journal Title:
Volume 21, Issue 05, 2005
Key Word:


  • [1]Albert DM, Jakobiec FA. Principles and practice of ophthalmology. Philadelphia: Saunders, 1994.2799-2812.
  • [2]Bech N, Fledelius HC, Rosenberg T. Retinopathy of prematurity 1974-1991:an analysis of the Danish register for the visually impaired. Acta Ophthalmol,1993, 210 Suppl:12-15.
  • [3]Palmer EA, Flynn JT, Hardy RJ, et al. Incidence and early course of retinopathy of prematurity: the Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology, 1991, 98:1628-1640.
  • [4]Kinsey V, Hemphill FM. Prelimimary report of a cooperative study of retrolental fibroplasia. Am J Ophthalmol, 1995, 40:166-174.
  • [5]Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity. Preliminary results. Arch Ophthalmol, 1988, 106: 471-479.
  • [6]Hartnett ME. Features associated with surgical outcome in patients with stages 4 and 5 retinopathy of prematurity. Retina, 2003, 23:322-329.
  • [7]The Committee for the Classification of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. Arch Ophthalmol, 1984, 102:1130-1134.
  • [8]Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol, 2003, 121:1684-1694.
  • [9]中华人民共和国卫生部.早产儿治疗用氧和视网膜病变防治指南.
  • [10]American Academy of Pediatrics, American Association for Pediatric Ophthalmology and Strabismus, American Academy of Ophthalmology. Screening examination of premature infants for retinopathy of prematurity. Pediatrics, 2001, 108:809-811.
  • [11]Retinopathy of prematurity: guidelines for screening and treatment. The report of a Joint Working Party of The Royal College of Ophthalmologists and the British Association of Perinatal Medicine. Early Hum Dev, 1996, 46:239-258.
  • [12]Chiang MC, Tang JR, Yau KI, et al. A proposal of screening guideline for retinopathy of prematurity in Taiwan. Acta Paediatr Taiwan, 2002, 43: 204-207.
  • [13]Trinavarat A, Atchaneeyasakul LO, Udompunturak S. Applicability of American and British criteria for screening of the retinopathy of prematurity in Thailand. Jpn J Ophthalmol, 2004, 48: 50-53.
  • [14]Ozaki H,Yu AY,Della N,et al. Hypoxia inducible factor-1alpha is increased in ischemic retina:temporal and spatial correlation with VEGF expression. Invest Ophthalmol Vis Sci, 1999, 40:182-189.
  • [15]Lorenz B, Bock M, Muller HM, et al. Telemedicine based screening of infants at risk for retinopathy of prematurity. Stud Health Technol Inform, 1999, 64:155-163.
  • [16]Gaynon MW,Stevenson DK,Sunshine P,et al. Supplemental oxygen may decrease progression of prethreshold disease to threshold retinopathy of prematurity. J Perinatol, 1997, 17: 434-438.
  • [17]The STOP-ROP Multicenter Study Group. Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP),a randomized,controlled trial I Primary outcomes. Pediatrics, 2000,105:295-310.
  • [18]Merritt JC, Kraybill EN. Effect of mydriatics on blood pressure in premature infants. J Pediatr Ophthalmol Strabismus, 1981,18:42-46.
  • [19]Rush R, Rush S, Nicolau J, et al. Systemic manifestations in response to mydriasis and physical examination during screening for retinopathy of prematurity. Retina, 2004, 24:242-245.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615